The Active Metabolite of Vitamin D3 as a Potential Immunomodulator

Scandinavian Journal of Immunology

Volumn 83, Issue 2, 2016, Pages 83-91

  Szymczak, I ^a   Pawliczak, R ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; CALCITRIOL; CATHELICIDIN; COD LIVER OIL; COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 27B1; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; IMMUNOLOGIC FACTOR;

ADAPTIVE IMMUNITY; ALLERGIC AIRWAY INFLAMMATION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BONE METABOLISM; CELL COMMUNICATION; CELL DIFFERENTIATION; CHOLESTEROL SYNTHESIS; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUBERCULOSIS; ANIMAL; BIOSYNTHESIS; DENDRITIC CELL; IMMUNOLOGY; METABOLISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; ANTIMICROBIAL CATIONIC PEPTIDES; B-LYMPHOCYTES; CALCIFEDIOL; CALCITRIOL; CHOLECALCIFEROL; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84955572340     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12403     Document Type: Review

References (108)

1. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-88S.
2. 3 in humans. J Clin Endocrinol Metab 2004;89:5387-91.
3. Logan VF, Gray AR, Peddie MC, Harper MJ, Houghton LA. Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months. Br J Nutr 2013;109:1082-8.
4. Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol 2006;54:301-17.
5. Querfeld U. Vitamin D and inflammation. Pediatr Nephrol 2012;28:605-10.
6. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys 2012;523:123-33.
7. Haussler MR, Haussler CA, Jurutka PW et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 1997;154 (3 Suppl):S57-73.
8. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726-76.
9. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology 2011;134:123-39.
10. Adams JS, Gacad MA. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985;161:755-65.
11. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634-47.
12. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-3.
13. Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol 2010;26:591-5.
14. White JH. Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord 2012;13:21-9.
15. Hewison M. Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Investig Suppl 2012;243:92-102.
16. Lang PO, Samaras D. Aging adults and seasonal influenza: does the vitamin d status (h)arm the body? J Aging Res 2012;2012:806198.
17. Lang PO, Samaras N, Samaras D, Aspinall R. How important is vitamin D in preventing infections? Osteoporos Int 2012;24:1537-53.
18. Bischoff-Ferrari HA, Dawson-Hughes B, Platz A et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 2010;170:813-20.
19. Lang PO, Aspinall R. Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response? Nutrients 2015;7:2044-60.
20. White JH, Vitamin D. Signaling, infectious diseases, and regulation of innate immunity. Infect Immun 2008;76:3837-43.
21. Olliver M, Spelmink L, Hiew J, Meyer-Hoffert U, Henriques-Normark B, Bergman P. Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae. J Infect Dis 2013;208:1474-81.
22. Tiosano D, Wildbaum G, Gepstein V et al. The role of vitamin D receptor in innate and adaptive immunity: a study in hereditary vitamin D-resistant rickets patients. J Clin Endocrinol Metab 2013;98:1685-93.
23. Lin R, White JH. The pleiotropic actions of vitamin D. BioEssays 2004;26:21-8.
24. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001;294:1866-70.
25. Yasmin R, Williams RM, Xu M, Noy N. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J Biol Chem 2005;280:40152-60.
26. Takeuchi A, Reddy GS, Kobayashi T, Okano T, Park J, Sharma S. Nuclear factor of activated T cells (NFAT) as a molecular target for 1α, 25-Dihydroxyvitamin D3-mediated effects. J Immunol 1998;160:209-18.
27. Takahashi K, Nakayama Y, Horiuchi H et al. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha, 25-dihydroxyvitamin D3. Immunopharmacol Immunotoxicol 2002;24:335-47.
28. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983;221:1181-3.
29. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008;8:685-98.
30. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 2011;11:584-96.
31. Holick MF. Vitamin D: extraskeletal health. Rheum Dis Clin North Am 2012;38:141-60.
32. Kundu R, Chain BM, Coussens AK, Khoo B, Noursadeghi M. Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. Eur J Immunol 2014;44:1781-90.
33. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012;76:315-25.
34. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010;10:482-96.
35. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheum Dis Clin N Am 2012;38:125-39.
36. Grad R. Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm Hist 2004;46:106-20.
37. Abe E, Miyaura C, Sakagami H et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981;78:4990-4.
38. Abe E, Miyaura C, Tanaka H et al. 1 alpha, 25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci USA 1983;80:5583-7.
39. Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca HF. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1, 25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 1984;44:5624-8.
40. Tanaka H, Abe E, Miyaura C, Shiina Y, Suda T. 1 alpha, 25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun 1983;117:86-92.
41. Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. 1, 25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993;82:1300-7.
42. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J 2005;19:1067-77.
43. Wang T-T, Nestel FP, Bourdeau V et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173:2909-12.
44. van der Does AM, Bergman P, Agerberth B, Lindbom L. Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections. J Leukoc Biol 2012;92:735-42.
45. Ramanathan B, Davis EG, Ross CR, Blecha F. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect 2002;4:361-72.
46. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007;449:819-26.
47. Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol Med 2007;13:117-24.
48. Liu PT, Schenk M, Walker VP et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 2009;4:e5810.
49. Agerberth B, Charo J, Werr J et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000;96:3086-93.
50. Chen Y, Liu W, Sun T et al. 1, 25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol 2013;190:3687-95.
51. Edfeldt K, Liu PT, Chun R et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 2010;107:22593-8.
52. Fabri M, Stenger S, Shin D-M et al. Vitamin D Is Required for IFN-γ-Mediated Antimicrobial Activity of Human Macrophages. Sci Transl Med 2011;3:104ra102.
53. Battersby AJ, Kampmann B, Burl S. Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol [Internet] 2012. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398646/ [accessed 31 May 2015].
54. Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, Mathieu C. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 2006;21:37-47.
55. Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Törmä H, Stahle M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005;124:1080-2.
56. Sadeghi K, Wessner B, Laggner U et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006;36:361-70.
57. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008;181:7090-9.
58. Adams JS, Ren S, Liu PT et al. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009;182:4289-95.
59. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000;290:1717-21.
60. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007;7:767-77.
61. Bacchetta J, Zaritsky JJ, Sea JL et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol 2014;25:564-72.
62. Cherayil BJ. The role of iron in the immune response to bacterial infection. Immunol Res 2011;50:1-9.
63. Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol 2014;5:151.
64. Sørensen O, Cowland JB, Askaa J, Borregaard N. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 1997;206:53-9.
65. van Driel M, Koedam M, Buurman CJ et al. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 2006;20:2417-19.
66. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
67. Rigby WF, Waugh MG. Decreased accessory cell function and costimulatory activity by 1, 25-dihydroxyvitamin D3-treated monocytes. Arthritis Rheum 1992;35:110-19.
68. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449:419-26.
69. Brennan A, Katz DR, Nunn JD et al. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 1987;61:457-61.
70. Hewison M, Freeman L, Hughes SV et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003;170:5382-90.
71. Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab 2011;25:617-32.
72. Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc 2012;71:50-61.
73. Penna G, Amuchastegui S, Giarratana N et al. 1, 25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells. J Immunol 2007;178:145-53.
74. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1, 25-Dihydroxyvitamin D3 Receptor in the Immune System. Arch Biochem Biophys 2000;374:334-8.
75. Ferreira GB, van Etten E, Verstuyf A, Waer M, Overbergh L, Gysemans C, et al. 1, 25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev 2011;27:933-41.
76. Panda DK, Miao D, Tremblay ML et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001;98:7498-503.
77. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001;98:6800-5.
78. Enioutina EY, Bareyan D, Daynes RA. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 2009;182:4296-305.
79. Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984;74:657-61.
80. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003;89:922-32.
81. van Etten E, Mathieu C. Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93-101.
82. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995;15:5789-99.
83. Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol Aspects Med 2012;33:77-82.
84. 2 vitamin D. Rheumatol Int 2012;32:845-52.
85. Jeffery LE, Burke F, Mura M et al. 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009;183:5458-67.
86. Peck A, Mellins ED. Precarious balance: Th17 cells in host defense. Infect Immun 2010;78:32-8.
87. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1, 25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985;134:3032-5.
88. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995;125 (6 Suppl):1704S-8S.
89. Palmer MT, Lee YK, Maynard CL et al. Lineage-specific effects of 1, 25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 2011;286:997-1004.
90. Baeke F, Korf H, Overbergh L et al. The vitamin D analog, TX527, promotes a human CD4+ CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2011;186:132-42.
91. Cantorna MT. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 2010;69:286-9.
92. Giulietti A, Gysemans C, Stoffels K et al. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004;47:451-62.
93. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001;167:4974-80.
94. Van Overtvelt L, Lombardi V, Razafindratsita A et al. IL-10-Inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 2008;145:152-62.
95. 3 pretreatment enhances the efficacy of allergen immunotherapy in a mouse allergic asthma model. Chin Med J (Engl) 2010;123:3591-6.
96. Heine G, Tabeling C, Hartmann B et al. 25-Hydroxvitamin D3 promotes the long-term effect of specific immunotherapy in a murine allergy model. J Immunol 2014;193:1017-23.
97. Jirapongsananuruk O, Melamed I, Leung DY. Additive immunosuppressive effects of 1, 25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 2000;106:981-5.
98. Xystrakis E, Kusumakar S, Boswell S et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006;116:146-55.
99. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) 2010;88:441-50.
100. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010;11:344-9.
101. Vernino L, McAnally LM, Ramberg J, Lipsky PE. Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells. J Immunol 1992;148:404-10.
102. Grammer AC, Lipsky PE. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 2003;5 (Suppl 4):S22-7.
103. Shirakawa A-K, Nagakubo D, Hieshima K, Nakayama T, Jin Z, Yoshie O. 1, 25-Dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells. J Immunol 2008;180:2786-95.
104. Heine G, Niesner U, Chang H-D et al. 1, 25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 2008;38:2210-18.
105. Jones AP, Tulic MK, Rueter K, Prescott SL. Vitamin D and allergic disease: sunlight at the end of the tunnel? Nutrients 2012;4:13-28.
106. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007;13:460-9.
107. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases RSV induction of NF-κB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010;184:965-74.
108. McNally P, Coughlan C, Bergsson G et al. Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. J Cyst Fibros 2011;10:428-34.